Congenital generalized lipodystrophy type 1
Other Names for this Disease
- Berardinelli-Seip congenital lipodystrophy type 1
- Brunzell syndrome, AGPAT2-related
- The NORD Physician Guide for Congenital generalized lipodystrophy type 1 was developed as a free service of the National Organization for Rare Disorders (NORD) and it's medical advisors. The guides provide a resource for clinicians about specific rare disorders to facilitate diagnosis and treatment of their patients with this condition.
(Amylin Pharmaceuticals, LLC)
The FDA has approved this product to be used in this manner.
|Adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy.|
|More Information about this product||Drug Information Portal|